Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra and lamivudine salvage therapy in HIV-1
NCT01002898Phase 3Completed
- Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Start
- Apr 2007
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Bamrasnaradura Infectious Diseases Institute. Started Apr 2007; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01002898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002898.